Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Special Features
Special Features
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2014
2013
2012
2011
2010
2009
2008
2007
2006
10-Oct-2013
Edition 524 - Mesoblast Acquires Osiris’ ceMSC Assets
3-Oct-2013
Edition 523 - Quarterly Review - Biotech Stocks Power Ahead
27-Sep-2013
Edition 522 - Somnomed to Launch New Products in FY14 and Complete Trials to Support Compliance Claims
20-Sep-2013
Edition 521 - Perth Biotech Briefing
13-Sep-2013
Edition 520 - Biotech Bull Market Special Edition Bioshares Top 10 Picks
6-Sep-2013
Edition 519 - Invion – Three Phase II Readouts Approaching and No Cash Required
30-Aug-2013
Edition 518 - Mesoblast Updates Market on Phase III CHF Trial
23-Aug-2013
Edition 517 - Cogstate Results – Investing to Expand Markets and Applications
16-Aug-2013
Edition 516 - Sirtex Medical Nudges $100 Million in Sales; Retains Cash of $52 Million
9-Aug-2013
Edition 515 - The Oncosil Medical Plan – Follow Sirtex!
Previous
1
2
3
4
5
Next